SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Restructurings

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: pgo-neil10/4/2009 1:03:58 PM
  Read Replies (1) of 270
 
DCGN closes Chicago operations. Cuts about 20% of staff. If anything, the future looks more grim with additional debt. [Who would lend them more money?]

biz.yahoo.com

Item 1.01. Entry into A Material Definitive Agreement
(a) On September 25, 2009, the secured promissory note dated September 11, 2009, among deCODE genetics, Inc., MediChem Life Sciences, Inc., deCODE Biostructures, Inc. and Saga Investments LLC was amended to increase the principal amount thereof to $1,870,000. All other terms of such note, which is further described in the Current Report on Form 8-K filed by deCODE genetics, Inc. on September 17, 2009, remain in place.

Item 2.05. Costs Associated with Exit or Disposal Activities
(a) On September 24, 2009, in order to conserve its financial resources, deCODE genetics, Inc. ("deCODE") committed to the closing of its facility in Woodridge, Illinois. As part of the closure, deCODE eliminated approximately 60 positions, effective principally from September 25, 2009. Remaining operations are expected to cease as soon as practical.

(b) deCODE estimates that it in connection with the closure of, and winding down of operations at, the facility, it will incur cash expenditures of approximately $580,000 in employee-related costs, $150,000 in chemical disposal costs, $150,000 in utility costs, and $460,000 in contract termination fees.

(c) deCODE estimates that it will incur a total of approximately $1,500,000 in cash expenditures connection with the closure of the facility and the winding down of operations.

(d) Closure of the Woodridge facility has resulted in a default by deCODE's subsidiary, deCODE Chemistry, Inc., under its lease for the facility and the draw by the landlord under such lease on the $5,000,000 letter of credit securing the lease. The amount of additional charges that deCODE may incur under generally accepted accounting principles in connection with such default and draw will depend, in part, on actions to be taken by the landlord under the lease. Accordingly, deCODE cannot at this time estimate the total charges. However, it does not expect that the total cost will result in future cash expenditures other than those set forth above.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext